ARRDC3 as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer Based on Data Mining
Yanli Chen,1– 3 Dan Tian,1 Xiaoqi Chen,1 Zhi Tang,1 Kuina Li,1 Zhijiong Huang,1 Yong Fu,4 Yanying Feng,4 Zhijun Yang1,3 1Department of Gynecologic Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People’s Republic of China; 2Department of Obstetrics and Gyn...
Main Authors: | Chen Y, Tian D, Chen X, Tang Z, Li K, Huang Z, Fu Y, Feng Y, Yang Z |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-03-01
|
Series: | International Journal of General Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/arrdc3-as-a-diagnostic-and-prognostic-biomarker-for-epithelial-ovarian-peer-reviewed-article-IJGM |
Similar Items
-
A Potential Indicator ARRDC2 Has Feasibility to Evaluate Prognosis and Immune Microenvironment in Ovarian Cancer
by: Mengjun Zhang, et al.
Published: (2022-05-01) -
Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer
by: Mengjun Zhang, et al.
Published: (2022-08-01) -
Through the Looking Glass: Updated Insights on Ovarian Cancer Diagnostics
by: Sourav Chakraborty, et al.
Published: (2023-02-01) -
PER1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Ovarian Cancer
by: Mali Chen, et al.
Published: (2021-06-01) -
Prognostic significance of HOXD4 protein expression in human ovarian cancers
by: Bo Yu, et al.
Published: (2021-11-01)